James M Stone
James M Stone
Brighton and Sussex Medical School; University of Sussex; University of Brighton
Verified email at bsms.ac.uk
Title
Cited by
Cited by
Year
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
RL Carhart-Harris, D Erritzoe, T Williams, JM Stone, LJ Reed, A Colasanti, ...
Proceedings of the National Academy of Sciences 109 (6), 2138-2143, 2012
7762012
Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
S Bhattacharyya, PD Morrison, P Fusar-Poli, R Martin-Santos, ...
Neuropsychopharmacology 35 (3), 764-774, 2010
6312010
Glutamate and dopamine in schizophrenia: An update for the 21st century
O Howes, R McCutcheon, J Stone
Journal of psychopharmacology 29 (2), 97-115, 2015
5972015
Glutamate and dopamine dysregulation in schizophrenia—a synthesis and selective review
JM Stone, PD Morrison, LS Pilowsky
Journal of psychopharmacology 21 (4), 440-452, 2007
4632007
Complex I inhibitors induce dose‐dependent apoptosis in PC12 cells: relevance to Parkinson's disease
A Hartley, JM Stone, C Heron, JM Cooper, AHV Schapira
Journal of neurochemistry 63 (5), 1987-1990, 1994
4451994
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
A Englund, PD Morrison, J Nottage, D Hague, F Kane, S Bonaccorso, ...
Journal of psychopharmacology 27 (1), 19-27, 2013
3672013
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
LS Pilowsky, RA Bressan, JM Stone, K Erlandsson, RS Mulligan, ...
Molecular psychiatry 11 (2), 118-119, 2006
3022006
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function
A Demjaha, A Egerton, RM Murray, S Kapur, OD Howes, JM Stone, ...
Biological psychiatry 75 (5), e11-e13, 2014
2532014
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study
A Mechelli, A Riecher-Rössler, EM Meisenzahl, S Tognin, SJ Wood, ...
Archives of general psychiatry 68 (5), 489-495, 2011
2472011
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
JM Stone, C Dietrich, R Edden, MA Mehta, S De Simoni, LJ Reed, ...
Molecular psychiatry 17 (7), 664-665, 2012
2452012
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume
JM Stone, F Day, H Tsagaraki, I Valli, MA McLean, DJ Lythgoe, ...
Biological psychiatry 66 (6), 533-539, 2009
2442009
Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis
RL Carhart-Harris, R Leech, D Erritzoe, TM Williams, JM Stone, J Evans, ...
Schizophrenia bulletin 39 (6), 1343-1351, 2013
1712013
Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia
A Egerton, S Brugger, M Raffin, GJ Barker, DJ Lythgoe, PK McGuire, ...
Neuropsychopharmacology 37 (11), 2515-2521, 2012
1692012
Functional neuroimaging in schizophrenia: diagnosis and drug discovery
P McGuire, OD Howes, J Stone, P Fusar-Poli
Trends in pharmacological sciences 29 (2), 91-98, 2008
1622008
Proton magnetic resonance spectroscopy and illness stage in schizophrenia—a systematic review and meta-analysis
S Brugger, JM Davis, S Leucht, JM Stone
Biological psychiatry 69 (5), 495-503, 2011
1572011
Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive
E Mouchlianitis, MAP Bloomfield, V Law, K Beck, S Selvaraj, N Rasquinha, ...
Schizophrenia bulletin 42 (3), 744-752, 2016
1432016
Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis
JM Stone, OD Howes, A Egerton, J Kambeitz, P Allen, DJ Lythgoe, ...
Biological psychiatry 68 (7), 599-602, 2010
1322010
Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis
P Fusar-Poli, JM Stone, MR Broome, I Valli, A Mechelli, MA McLean, ...
Archives of general psychiatry 68 (9), 881-890, 2011
1272011
Drug models of schizophrenia
H Steeds, RL Carhart-Harris, JM Stone
Therapeutic advances in psychopharmacology 5 (1), 43-58, 2015
1212015
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123 I] CNS-1261 SPET study
JM Stone, K Erlandsson, E Arstad, L Squassante, V Teneggi, RA Bressan, ...
Psychopharmacology 197 (3), 401-408, 2008
1082008
The system can't perform the operation now. Try again later.
Articles 1–20